Inventor · disambiguated record
Anthony William James Cooper
Also filed as: COOPER ANTHONY · COOPER ANTHONY W · COOPER ANTHONY W J · COOPER ANTHONY WILLIAM JAMES
25 granted patents·10 pending applications·58 citations·filing 1988–2025
93Inventor score
Files withGLAXO GROUP LTD8SCHOLAR ROCK INC5GLAXOSMITHKLINE IP DEV LTD4COOPER ANTHONY WILLIAM JAMES3ASTEX THERAPEUTICS LTD2
Top patents by PatentIndex Score
35 records- 0185US12122823B2Isoform-selective TGFB1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Granted Oct 22, 2024·1 cites·13 claims
- 0281US8247377B2Non-steroidal glucocorticoid inhibitors and their use in treating inflammation, allergy and auto-immune conditionsBARNETT HEATHER ANNE·Filed 2007·Granted Aug 21, 2012·10 cites·21 claims
- 0381US2025084077A1Ether linked triazoles as nrf2 activatorsASTEX THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 0478US7528148B2Pyrazolo[3,4-B]pyridine compounds, and their use as phosphodiesterase inhibitorsGLAXO GROUP LTD·Filed 2003·Granted May 5, 2009·14 cites·52 claims
- 0577US11130803B2Isoform-selective TGFβ1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0677US2025215072A1Isoform-selective tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 0776US10428026B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2016·Granted Oct 1, 2019·2 cites·25 claims
- 0876US8178573B2CompoundsBIGGADIKE KEITH·Filed 2007·Granted May 15, 2012·2 cites·12 claims
- 0975US7678801B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 16, 2010·2 cites·76 claims
- 1072US4985407ADipeptide compounds, processes for their preparation and compositions containing themGLAXO GROUP LTD·Filed 1988·Granted Jan 15, 1991·19 cites·20 claims
- 1171US7947727B2CompoundsGLAXOGROUPLTD·Filed 2007·Granted May 24, 2011·3 cites·10 claims
- 1270US7465743B2Pyrazolo[3,4-b]pyridine compounds, and their use as PDE4 inhibitorsGLAXO GROUP LTD·Filed 2005·Granted Dec 16, 2008·1 cites·24 claims
- 1369US12091409B2Ether linked triazoles as NRF2 activatorsASTEX THERAPEUTICS LTD·Filed 2021·Granted Sep 17, 2024·0 cites·9 claims
- 1466US10927080B2Pyridinone dicarboxamide for use as bromodomain inhibitorsGLAXOSMITHKLINE IP NO 2 LTD·Filed 2019·Granted Feb 23, 2021·0 cites·8 claims
- 1565US8207176B2CompoundsCALLAHAN JAMES F·Filed 2006·Granted Jun 26, 2012·1 cites·31 claims
- 1665US7384946B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2004·Granted Jun 10, 2008·2 cites·19 claims
- 1764US11059816B2Ether linked triazoles as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Jul 13, 2021·0 cites·4 claims
- 1864US8354416B27,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinaseGLAXO GROUP LTD·Filed 2008·Granted Jan 15, 2013·0 cites·30 claims
- 1963US12252531B2Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitorsSCHOLAR ROCK INC·Filed 2019·Granted Mar 18, 2025·0 cites·5 claims
- 2061US10793559B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 6, 2020·0 cites·3 claims
- 2160US7943651B2CompoundsGLAXO GROUP LTD·Filed 2007·Granted May 17, 2011·0 cites·6 claims
- 2258US2025257125A1HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 2353US10457674B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Oct 29, 2019·0 cites·9 claims
- 2447US2010016331A1Novel compoundsBIGGADIKE KEITH·Filed 2007·Application pending·0 cites
- 2542US9156791B2Pyrazole compounds acting against allergic, immune and inflammatory conditionsCOOPER ANTHONY WILLIAM JAMES·Filed 2011·Granted Oct 13, 2015·0 cites·10 claims
- 2642US7932247B2M3 muscarinic acetylcholine receptor antagonistsGLAXO GROUP LTD·Filed 2005·Granted Apr 26, 2011·0 cites·4 claims
- 2742US2012277279A1Non-Steroidal Glucocorticoid Inhibitors and Their Use in Treating Inflammation, Allergy and Auto-Immune ConditionsBARNETT HEATHER ANNE·Filed 2012·Application pending·0 cites
- 2840US2010035926A1Pyrazole derivatives as non-steroidal glucocorticoid receptor ligandsCAMPBELL IAN BAXTER·Filed 2007·Application pending·0 cites
- 2940US2008249127A1Muscarinic Acetylcholine Receptor AntagonistsLAINE DRAMANE I·Filed 2005·Application pending·0 cites
- 3038US2007185090A1Muscarinic acetylchoine receptor antagonistsBUSCH-PETERSEN JAKOB·Filed 2004·Application pending·0 cites
- 3137US11078216B2Bisaryl amides as NRF2 activatorsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Aug 3, 2021·0 cites·18 claims
- 3237US2008287487A1Muscarinic Acetylcholine Receptor AntagonistsCOOPER ANTHONY WILLIAM JAMES·Filed 2005·Application pending·0 cites
- 3334US9149462B2Pyrazole compounds acting against allergic, inflammatory and immune disordersCOOPER ANTHONY WILLIAM JAMES·Filed 2011·Granted Oct 6, 2015·0 cites·10 claims
- 3434US2012035237A1Pyrazole and triazole carboxamides as crac chann el inhibitorsCOE DIANE MARY·Filed 2010·Application pending·0 cites
- 3526US8399436B2N-pyrazolyl carboxamides as CRAC channel inhibitorsALLEN DAVID GEORGE·Filed 2010·Granted Mar 19, 2013·0 cites·11 claims
Join the waitlist — get patent alerts
Get an alert when Anthony William James Cooper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →